Iqbal Hussain
Equibles does not estimate personal net worth.
Get an email with a short summary when Centessa Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.
Get CNTA alertsAbout Iqbal Hussain
Iqbal Hussain is recorded as General Counsel at Centessa Pharmaceuticals plc (CNTA). The newest filing on record that lists Iqbal Hussain as General Counsel at Centessa Pharmaceuticals plc (CNTA) is dated May 6, 2025. The proxy statement of Centessa Pharmaceuticals plc reports total compensation of $2,046,325 for Iqbal Hussain in fiscal 2024, including a base salary of $487,527. Disclosed compensation is on record for 2 fiscal years. Centessa Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Centessa Pharmaceuticals plc includes Mario Alberto Accardi (CEO and Board Member), Francesco De Rubertis (Chairman), John Crowley (CFO) and 7 others.
Affiliation history
-
Centessa Pharmaceuticals plc (CNTA)
Proxy statement
CurrentStart not stated–present
Last confirmed April 29, 2026
-
Current
Start not stated–present
Last confirmed May 6, 2025
Company network
Leadership on record at Centessa Pharmaceuticals plc
- Mario Alberto Accardi CEO, Board Member
- Francesco De Rubertis Chairman
- John Crowley CFO
- Thomas Templeman CTO
- Gregory Weinhoff Chief Accounting Officer
- Gregory Weinhoff, M.D., M.B.A. Chief Accounting Officer
- Raphael Deferiere Chief Accounting Officer
- Raphael Deferiere, CPA Chief Accounting Officer
- Christopher Stokes Board Member
- Kristina Mignon Wright Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | $487,527 | $2,046,325 |
| 2023 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | $452,711 | $1,181,713 |
Recent activity
No call appearances or filed executive changes recorded yet.